<SUBMISSION>
<ACCESSION-NUMBER>0000935836-09-000225
<TYPE>SC 13G/A
<PUBLIC-DOCUMENT-COUNT>1
<FILING-DATE>20090217
<DATE-OF-FILING-DATE-CHANGE>20090213
<SUBJECT-COMPANY>
<COMPANY-DATA>
<CONFORMED-NAME>CRITICAL PATH INC
<CIK>0001060801
<ASSIGNED-SIC>7389
<IRS-NUMBER>911788300
<STATE-OF-INCORPORATION>CA
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>SC 13G/A
<ACT>34
<FILE-NUMBER>005-56169
<FILM-NUMBER>09606304
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>2 HARRISON STREET
<STREET2>2ND FLOOR
<CITY>SAN FRANCISCO
<STATE>CA
<ZIP>94105
<PHONE>4158088800
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>2 HARRISON STREET
<STREET2>2ND FLOOR
<CITY>SAN FRNACISCO
<STATE>CA
<ZIP>94105
</MAIL-ADDRESS>
</SUBJECT-COMPANY>
<FILED-BY>
<COMPANY-DATA>
<CONFORMED-NAME>APEX CAPITAL LLC
<CIK>0000943518
<IRS-NUMBER>680347819
<STATE-OF-INCORPORATION>CA
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>SC 13G/A
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>25 ORINDA WAY
<STREET2>SUITE 300
<CITY>ORINDA
<STATE>CA
<ZIP>94563
<PHONE>925-253-1800
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>25 ORINDA WAY
<STREET2>SUITE 300
<CITY>ORINDA
<STATE>CA
<ZIP>94563
</MAIL-ADDRESS>
</FILED-BY>
<DOCUMENT>
<TYPE>SC 13G/A
<SEQUENCE>1
<FILENAME>critical13g.txt
<TEXT>
CUSIP No. 22674V506

                                   Page 2 of 7
SEC                       Page 1 of 7
                                                   ------------------
                  UNITED STATES                      OMB APPROVAL
        SECURITIES AND EXCHANGE COMMISSION         OMB Number:
              Washington, D.C. 20549               3235-0145
                                                   Expires:
                                                   December 31, 2009
                                                   Estimated
                                                   average burden
                                                   hours per
                                                   response 10.4
                                                   ------------------


                                  SCHEDULE 13G

                   Under the Securities Exchange Act of 1934
                                (Amendment No. 4)



                               Critical Path, Inc.

                                (Name of Issuer)


                                  Common Stock

                         (Title of Class of Securities)


                                    22674V506

                                 (CUSIP Number)


                                December 31, 2008

            (Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:

[ X ] Rule 13d-1(b)

[   ] Rule 13d-1(c)

[   ] Rule 13d-1(d)

* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).

Potential persons who are to respond to the collection of information contained
in this form are not required to respond unless the form displays a currently
valid OMB control number.




<PAGE>





      1. Names of Reporting Persons.

           Apex Capital, LLC


      2. Check the Appropriate Box if a Member of a Group (See Instructions)

           (a)
                -----

           (b)  X
                - ---


      3. SEC Use Only


      4. Citizenship or Place of Organization California

----------------------------------------------------------------------
Number of      5.    Sole Voting Power        0
Shares
Beneficially
Owned by
Each Reporting
Person With:
               -------------------------------------------------------
               -------------------------------------------------------
               6. Shared Voting Power 0

               -------------------------------------------------------
               -------------------------------------------------------
               7. Sole Dispositive Power 0
               -------------------------------------------------------
               -------------------------------------------------------
               8. Shared Dispositive Power 0
               -------------------------------------------------------

      9. Aggregate Amount Beneficially Owned by Each Reporting Person 0


      10.  Check if the Aggregate Amount in Row (9) Excludes Certain Shares
           (See
           Instructions)                                     ______


      11.  Percent of Class Represented by Amount in Row (9)     0%


      12. Type of Reporting Person (See Instructions) OO, IA




<PAGE>





      1. Names of Reporting Persons.

           Sanford J. Colen


      2. Check the Appropriate Box if a Member of a Group (See Instructions)

           (a)
                -----

           (b)  X
                - ---


      3. SEC Use Only


      4. Citizenship or Place of Organization United States

----------------------------------------------------------------------
Number of      5.    Sole Voting Power        0
Shares
Beneficially
Owned by
Each Reporting
Person With:
               -------------------------------------------------------
               -------------------------------------------------------
               6. Shared Voting Power 0

               -------------------------------------------------------
               -------------------------------------------------------
               7. Sole Dispositive Power 0
               -------------------------------------------------------
               -------------------------------------------------------
               8. Shared Dispositive Power 0
               -------------------------------------------------------

      9. Aggregate Amount Beneficially Owned by Each Reporting Person 0


      10.  Check if the Aggregate Amount in Row (9) Excludes Certain Shares
           (See
           Instructions)                                     ______


      11.  Percent of Class Represented by Amount in Row (9)     0%


      12. Type of Reporting Person (See Instructions) IN, HC




<PAGE>


Item 1.

      (a)  Name of Issuer

           Critical Path, Inc.


      (b)  Address of Issuer's Principal Executive Offices

           42-47 Lower Mount Street, Dublin 2, Ireland


Item 2.

      (a) The names of the persons filing this statement are:

           Apex Capital, LLC ("LLC")

           Sanford J. Colen ("Colen")









           (collectively, the "Filers").

      (b) The principal business office of the Filers is located at:

           25 Orinda Way, Suite 300, Orinda, CA  94563





      (c)  For citizenship of Filers, see Item 4 of the cover sheet for each
           Filer.

      (d)  This statement relates to shares of common stock of the Issuer (the
           "Stock").

      (e)  The CUSIP number of the Issuer is: 22674V506


<PAGE>


Item       3. If this statement is filed pursuant to rule 240.13d-1(b) or
           240.13d-2(b) or (c), check whether the person filing is a:

(a) [ ]Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

(b) [ ]Bank as defined in section 3(a)(6) of the Act (15 U.S.C.
                78c).

(c)  [ ]Insurance company as defined in section 3(a)(19) of the Act
                (15 U.S.C. 78c).

(d)  [ ]Investment company registered under section 8 of the Investment Company
        Act of 1940(15 U.S.C. 80a-8).

(e) [ X ]An investment adviser in accordance with section
         240.13d-1(b)(1)(ii)(E) (as to LLC).

(f) [ ]An employee benefit plan or endowment fund in accordance with
                section 240.13d-1(b)(1)(ii)(F).

(g) [ X ]A parent holding company or control person in accordance
                with 240.13d-1(b)(1)(ii)(G) (as to Colen).

(h) [ ]A savings association as defined in section 3(b) of the
                Federal Deposit Insurance Act (12 U.S.C. 1813).

(i) [ ]A church plan that is excluded from the definition of an
       investment company under section 3(c)(14) of the Investment
       Company Act of 1940 (15 U.S.C. 80a-3).

(j) [ ]A non-U.S. institution in accordance with
       ss.240.13d-1(b)(ii)(J).

(k)       [ ]Group, in accordance with Rule 13d-1(b)(1)(ii)(K).


Item 4.    Ownership.

See Items 5-9 and 11 of the cover page for each Filer.

Item 5.    Ownership of Five Percent or Less of a Class

If this statement is being filed to report the fact that as of the date hereof
the reporting person has ceased to be the beneficial owner of more than five
percent of the class of securities, check the following [ X ].

Item 6. Ownership of More than Five Percent on Behalf of Another Person.

Not applicable.

Item 7.    Identification and Classification of the Subsidiary Which Acquired
           the Security Being Reported on By the Parent Holding Company.

Not applicable.

Item 8.    Identification and Classification of Members of the Group.

LLC is a registered investment adviser. Colen is the controlling member of LLC.
The Filers are filing this Schedule 13G jointly, but not as members of a group,
and each of them expressly disclaims membership in a group. Each of the Filers
also disclaims beneficial ownership of the Stock except to the extent of that
Filer's pecuniary interest therein.

Item 9.    Notice of Dissolution of Group

Not applicable.

Item 10.   Certification.

By signing below I certify that, to the best of my knowledge and belief, the
securities referred to above were acquired and are held in the ordinary course
of business and were not acquired and are not held for the purpose of or with
the effect of changing or influencing the control of the issuer of the
securities and were not acquired and are not held in connection with or as a
participant in any transaction having that purpose or effect.

                                    SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.

Dated:     February 13, 2009

APEX CAPITAL, LLC


By:   Sanford J. Colen, Manager



Sanford J. Colen




<PAGE>


                                    EXHIBIT A

                        AGREEMENT REGARDING JOINT FILING
                       OF STATEMENT ON SCHEDULE 13D OR 13G

The undersigned agree to file jointly with the Securities and Exchange
Commission (the "SEC") any and all statements on Schedule 13D or Schedule 13G
(and any amendments or supplements thereto) required under section 13(d) of the
Securities Exchange Act of 1934, as amended, in connection with purchases by the
undersigned of securities of any issuer, until such time as the undersigned file
with the SEC a statement terminating this Agreement Regarding Joint Filing of
Statement on Schedule 13D or 13G. For that purpose, the undersigned hereby
constitute and appoint Apex Capital, LLC, a California limited liability
company, as their true and lawful agent and attorney-in-fact, with full power
and authority for and on behalf of the undersigned to prepare or cause to be
prepared, sign, file with the SEC and furnish to any other person all
certificates, instruments, agreements and documents necessary to comply with
section 13(d) and section 16(a) of the Securities Exchange Act of 1934, as
amended, in connection with said purchases, and to do and perform every act
necessary and proper to be done incident to the exercise of the foregoing power,
as fully as the undersigned might or could do if personally present, until such
time as the undersigned file with the SEC a statement terminating this Agreement
Regarding Joint Filing of Statement on Schedule 13D or 13G.

Dated:     February 10, 2005

SANFORD J. COLEN                    DANIEL S. KATZ

/s/ Sanford J. Colen                /s/ Daniel S. Katz

APEX CAPITAL, LLC

By:   /s/ Sanford J. Colen, Manager






Q:\EDGAR EasePlus\4341 apex Capital\critical path 13g\critical13g.rtf

</TEXT>
</DOCUMENT>
</SUBMISSION>
